NDC properties for "Bethkis 300 MG per 4 ML Inhalation Solution" (RxCUI 1314768)
About this data
The tables show NDC propoerties for Bethkis 300 MG per 4 ML Inhalation Solution with the RxCUI 1314768
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Bethkis 300 MG per 4 ML Inhalation Solution (RxCUI 1314768)
| MMSL_CODE | BD24800 |
|---|---|
| NDA | NDA201820 |
| RxCUI | 1314768 |
| SPL_SET_ID | 1cd3d47b-025f-4705-9daf-cf07725ec223 |
| Prescribable Synonym | Bethkis 300 MG per 4 ML Inhalation Solution |
| RXNAV_STR | Bethkis 75 MG/ML Inhalation Solution |
| RxNorm Name | tobramycin 75 MG/ML Inhalation Solution [Bethkis] |
| RxNorm Synonym | Bethkis 300 MG per 4 ML Inhalation Solution |
| RxNorm Synonym | Bethkis 75 MG/ML Inhalation Solution |
| Related queries | Interactions (for RxCUI 1314768) |
NDC Properties
NDC Item 10122082004
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-04 |
| NDC Item | 10122082004 |
| Packaging | 4 AMPULE in 1 POUCH (10122-820-04) / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082028
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-28 |
| NDC Item | 10122082028 |
| Packaging | 7 POUCH in 1 CARTON (10122-820-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082056
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-56 |
| NDC Item | 10122082056 |
| Packaging | 14 POUCH in 1 CARTON (10122-820-56) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082004
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-04 |
| NDC Item | 10122082004 |
| Packaging | 4 AMPULE in 1 POUCH (10122-820-04) / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082028
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-28 |
| NDC Item | 10122082028 |
| Packaging | 7 POUCH in 1 CARTON (10122-820-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082056
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-56 |
| NDC Item | 10122082056 |
| Packaging | 14 POUCH in 1 CARTON (10122-820-56) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082004
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-04 |
| NDC Item | 10122082004 |
| Packaging | 4 AMPULE in 1 POUCH (10122-820-04) / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082028
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-28 |
| NDC Item | 10122082028 |
| Packaging | 7 POUCH in 1 CARTON (10122-820-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |
NDC Item 10122082056
| NDC 9 | 10122-820 |
|---|---|
| NDC 10 | 10122-820-56 |
| NDC Item | 10122082056 |
| Packaging | 14 POUCH in 1 CARTON (10122-820-56) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| FDA SPL set id | 696600 |
| Labeler | Chiesi USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-04-15 |
| Marketing status | ACTIVE |
| NDA | NDA201820 |
| Related queries | Properties for NDC 9 10122-820 |